These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35777930)

  • 1. CD8 + T-cell responses in HIV controllers: potential implications for novel HIV remission strategies.
    Rutishauser RL; Trautmann L
    Curr Opin HIV AIDS; 2022 Sep; 17(5):315-324. PubMed ID: 35777930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.
    Bruel T; Hamimi C; Dereuddre-Bosquet N; Cosma A; Shin SY; Corneau A; Versmisse P; Karlsson I; Malleret B; Targat B; Barré-Sinoussi F; Le Grand R; Pancino G; Sáez-Cirión A; Vaslin B
    J Virol; 2015 Apr; 89(7):3542-56. PubMed ID: 25589645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of CD8
    McBrien JB; Kumar NA; Silvestri G
    Eur J Immunol; 2018 Jun; 48(6):898-914. PubMed ID: 29427516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute-Phase CD4
    Sutton MS; Ellis-Connell A; Moriarty RV; Balgeman AJ; Gellerup D; Barry G; Weiler AM; Friedrich TC; O'Connor SL
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadening of Virus-Specific CD8+ T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers.
    Nomura T; Yamamoto H; Ishii H; Akari H; Naruse TK; Kimura A; Matano T
    PLoS Pathog; 2015; 11(11):e1005247. PubMed ID: 26536034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Immunogen Selectively Eliciting CD8
    Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
    Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
    J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
    Front Immunol; 2018; 9():492. PubMed ID: 29616024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.
    Fujita T; Burwitz BJ; Chew GM; Reed JS; Pathak R; Seger E; Clayton KL; Rini JM; Ostrowski MA; Ishii N; Kuroda MJ; Hansen SG; Sacha JB; Ndhlovu LC
    J Immunol; 2014 Dec; 193(11):5576-83. PubMed ID: 25348621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
    Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD
    J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.
    Mudd PA; Ericsen AJ; Burwitz BJ; Wilson NA; O'Connor DH; Hughes AL; Watkins DI
    J Immunol; 2012 Apr; 188(7):3364-70. PubMed ID: 22387557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.
    Loffredo JT; Burwitz BJ; Rakasz EG; Spencer SP; Stephany JJ; Vela JP; Martin SR; Reed J; Piaskowski SM; Furlott J; Weisgrau KL; Rodrigues DS; Soma T; Napoé G; Friedrich TC; Wilson NA; Kallas EG; Watkins DI
    J Virol; 2007 Mar; 81(6):2624-34. PubMed ID: 17192314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Hau TTT; Nakamura-Hoshi M; Kanno Y; Nomura T; Nishizawa M; Seki S; Ishii H; Kawana-Tachikawa A; Hall WW; Nguyen Thi LA; Matano T; Yamamoto H
    Biochem Biophys Res Commun; 2019 Apr; 512(2):213-217. PubMed ID: 30878187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protective MHC-I haplotype not associated with dominant Gag-specific CD8+ T-cell responses in SIVmac239 infection of Burmese rhesus macaques.
    Takahashi N; Nomura T; Takahara Y; Yamamoto H; Shiino T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Miura T; Igarashi T; Koyanagi Y; Naruse TK; Kimura A; Matano T
    PLoS One; 2013; 8(1):e54300. PubMed ID: 23342126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SIV Nef CD8(+) T cell epitopes restricted by a MHC class I haplotype associated with lower viral loads in a macaque AIDS model.
    Nomura T; Yamamoto H; Takahashi N; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2014 Jul; 450(2):942-7. PubMed ID: 24971540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
    Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
    Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
    J Virol; 2018 May; 92(9):. PubMed ID: 29467313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Coreceptor CXCR4 Antagonists Promote Clonal Expansion of Viral Epitope-Specific CD8+ T Cells During Acute SIV Infection in Rhesus Monkeys In Vivo.
    Ding Q; Li S; Jiang Z; Yang Y; Yu H; Wei P; Liu Z; Huang J; Gong Y; Sun H
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):145-53. PubMed ID: 25714247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.
    Vemparala B; Madelain V; Passaes C; Millet A; Avettand-Fenoel V; Djidjou-Demasse R; Dereuddre-Bosquet N; Le Grand R; Rouzioux C; Vaslin B; Sáez-Cirión A; Guedj J; Dixit NM
    PLoS Comput Biol; 2024 Sep; 20(9):e1012434. PubMed ID: 39255323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.